Table 3.
Subgroup analysis—ICD related characteristics and adverse events during FU.
| Variables | Primary prev. ICD | Secondary prev. ICD | p-Value |
|---|---|---|---|
| (n = 57) | (n = 37) | ||
| Time to LVAD implantation (months), median (IQR)) | 18 (8–44) | 16 (6–34) | 0.20 |
| Patients with ICD related adverse events (ICD-AE), n (%) | 25 (43.9) | 15 (40.5) | 0.75 |
| Time to ICD-AE (months), median (IQR) | 4.0 (1–15) | 4.5 (1–12) | 0.60 |
| Lead dysfunction, n (%) | 10 (17.5) | 9 (24.3) | 0.42 |
| ICD reintervention, n (%) | 8 (14.0) | 3 (8.1) | 0.38 |
| Inappropriate shocks, n (%) | 3 (5.3) | 2 (5.4) | 0.98 |
| Appropriate shocks, n (%) | 12 (21.1) | 6 (16.2) | 0.56 |
| Ventricular arrythmias (VAs), n (%) | 18 (31.6) | 8 (21.6) | 0.29 |
| Time to VAs (months), median (IQR) | 7 (4–15) | 10 (6–17) | 0.55 |
AE, adverse event; ICD, implantable cardioverter defibrillator; LVAD, left ventricular assist device; Vas, ventricular arrhythmias.